Rationing tests for drug-resistant tuberculosis - who are we prepared to miss?
Martin, Laura J; Roper, Martha H; Grandjean, Louis; Gilman, Robert H; Coronel, Jorge; Caviedes, Luz; Friedland, Jon S; Moore, David A J.
; 14: 30, 2016 Mar 23.
Artigo em Inglês | MEDLINE | ID: mdl-27005771
Linezolid for drug-resistant pulmonary tuberculosis.
Assessing the effect of decentralisation of laboratory diagnosis for drug-resistant tuberculosis in Kenya.
Risk factors associated with MDR-TB at the onset of therapy among new cases registered with the RNTCP in Mumbai, India.
Strengthening the Tuberculosis Specimen Referral Network in Uganda: The Role of Public-Private Partnerships.
Molecular epidemiology of Mycobacterium tuberculosis in an urban area in Japan, 2002-2006.
Multidrug-resistant tuberculosis treatment adherence in migrants: a systematic review and meta-analysis.
Gridlock from diagnosis to treatment of multidrug-resistant tuberculosis in Tanzania: low accessibility of molecular diagnostic services and lack of healthcare worker empowerment in 28 districts of 5 high burden TB regions with mixed methods evaluation.
Treatment outcomes of the drug resistant tuberculosis cases previously exposed to second line anti Tuberculosis drugs in Pakistan: A multi-center cross-sectional study.
Time to poor treatment outcome and its predictors among drug-resistant tuberculosis patients on second-line anti-tuberculosis treatment in Amhara region, Ethiopia: retrospective cohort study.